Stocky turns companies like DAIKEN MEDICAL CO LTD into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. 7775.T shows mixed signals: Value Compounder strength (56/100) suggests reasonable valuation discipline, but Growth Compounder weakness (41/100) indicates modest revenue expansion and profitability gains. Leadership Alignment at 59/100 lacks the founder-CEO conviction or shareholder-friendly capital structures that drive long-term outperformance. The Vulnerable profile signals structural competitive or market headwinds that warrant close monitoring before committing capital.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for DAIKEN MEDICAL CO LTD:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 41/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates DAIKEN MEDICAL CO LTD (7775.T) at 41/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. 7775.T shows mixed signals: Value Compounder strength (56/100) suggests reasonable valuation discipline, but Growth Compounder weakness (41/100) indicates modest revenue expansion and profitability gains. Leadership Alignment at 5
7775.T's current Stocky Verdict is 41/100, placing it in the "Cautious" band. This composite combines a 56/100 Compounder score, 59/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for DAIKEN MEDICAL CO LTD yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
DAIKEN MEDICAL CO LTD scores 59/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
DAIKEN MEDICAL CO LTD's Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to DAIKEN MEDICAL CO LTD.
Sign up free and unlock the full analysis on 7775.T — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 7775.T in the app.
